Sanofi-Aventis (France) Loses Lovenox Patent, No Generics Just Yet

PARIS/LONDON, Feb 9 (Reuters) - French drugmaker Sanofi-Aventis (SASY.PA: Quote, Profile , Research) said on Friday a California court had invalidated its patent on top-selling bloodthinner Lovenox, sending its shares down around 1 percent.

>>> Discuss This Story